303 related articles for article (PubMed ID: 27237822)
1. Nanomedicine for Intra-Articular Drug Delivery in Rheumatoid Arthritis.
O'Mary H; Del Rincόn I; Cui Z
Curr Med Chem; 2016; 23(23):2490-506. PubMed ID: 27237822
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine for the Treatment of Rheumatoid Arthritis.
Jeong M; Park JH
Mol Pharm; 2021 Feb; 18(2):539-549. PubMed ID: 32502346
[TBL] [Abstract][Full Text] [Related]
3. A novel indomethacin/methotrexate/MMP-9 siRNA in situ hydrogel with dual effects of anti-inflammatory activity and reversal of cartilage disruption for the synergistic treatment of rheumatoid arthritis.
Yin N; Tan X; Liu H; He F; Ding N; Gou J; Yin T; He H; Zhang Y; Tang X
Nanoscale; 2020 Apr; 12(15):8546-8562. PubMed ID: 32243486
[TBL] [Abstract][Full Text] [Related]
4. Food-Derived Nanoscopic Drug Delivery Systems for Treatment of Rheumatoid Arthritis.
Han D; Chen Q; Chen H
Molecules; 2020 Jul; 25(15):. PubMed ID: 32752061
[TBL] [Abstract][Full Text] [Related]
5. Notch-1 siRNA and Methotrexate towards a Multifunctional Approach in Rhematoid Arthritis Management: a Nanomedicine Approach.
Zhao G; Zhang H
Pharm Res; 2018 Apr; 35(6):123. PubMed ID: 29679159
[TBL] [Abstract][Full Text] [Related]
6. Intra-articular drug delivery systems for the treatment of rheumatic diseases: a review of the factors influencing their performance.
Butoescu N; Jordan O; Doelker E
Eur J Pharm Biopharm; 2009 Oct; 73(2):205-18. PubMed ID: 19545624
[TBL] [Abstract][Full Text] [Related]
7. Ceria-based nanotheranostic agent for rheumatoid arthritis.
Kalashnikova I; Chung SJ; Nafiujjaman M; Hill ML; Siziba ME; Contag CH; Kim T
Theranostics; 2020; 10(26):11863-11880. PubMed ID: 33204316
[TBL] [Abstract][Full Text] [Related]
8. Non-Biologic Nanodelivery Therapies for Rheumatoid Arthritis.
Gouveia VM; Lima SA; Nunes C; Reis S
J Biomed Nanotechnol; 2015 Oct; 11(10):1701-21. PubMed ID: 26502635
[TBL] [Abstract][Full Text] [Related]
9. Direct chemotherapeutic dual drug delivery through intra-articular injection for synergistic enhancement of rheumatoid arthritis treatment.
Reum Son A; Kim DY; Hun Park S; Yong Jang J; Kim K; Ju Kim B; Yun Yin X; Ho Kim J; Hyun Min B; Keun Han D; Suk Kim M
Sci Rep; 2015 Oct; 5():14713. PubMed ID: 26424611
[TBL] [Abstract][Full Text] [Related]
10. Intra-articular leflunomide-loaded poly(ε-caprolactone) implants to treat synovitis in rheumatoid arthritis.
Gomes TF; Gualberto FCM; Perasoli FB; Andrade FP; Moura SAL; Da Silva GR
Pharmazie; 2019 Apr; 74(4):212-220. PubMed ID: 30940304
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine - advantages for their use in rheumatoid arthritis theranostics.
Xiao S; Tang Y; Lv Z; Lin Y; Chen L
J Control Release; 2019 Dec; 316():302-316. PubMed ID: 31715278
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicines for chronic non-infectious arthritis: the clinician's perspective.
Rubinstein I; Weinberg GL
Nanomedicine; 2012 Sep; 8 Suppl 1():S77-82. PubMed ID: 22640912
[TBL] [Abstract][Full Text] [Related]
13. Zyn-Linker delivery of antirheumatic agents.
Ohlsson-Wilhelm BM; McDevitt MR; Gray BD; Lorinc R; McIlvain HB; Sheth K; Weeks SA; Muirhead KA
Immunol Res; 1994; 13(2-3):82-95. PubMed ID: 7775811
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of intra-articular injections into the temporomandibular joint in patients with rheumatoid arthritis.
Vallon D; Akerman S; Nilner M; Petersson A
Swed Dent J; 2002; 26(4):149-58. PubMed ID: 12611144
[TBL] [Abstract][Full Text] [Related]
15. Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis.
Heo R; You DG; Um W; Choi KY; Jeon S; Park JS; Choi Y; Kwon S; Kim K; Kwon IC; Jo DG; Kang YM; Park JH
Biomaterials; 2017 Jul; 131():15-26. PubMed ID: 28371624
[TBL] [Abstract][Full Text] [Related]
16. Intra-articular drug delivery systems for joint diseases.
Rai MF; Pham CT
Curr Opin Pharmacol; 2018 Jun; 40():67-73. PubMed ID: 29625332
[TBL] [Abstract][Full Text] [Related]
17. Nanotherapeutics relieve rheumatoid arthritis.
Yang M; Feng X; Ding J; Chang F; Chen X
J Control Release; 2017 Apr; 252():108-124. PubMed ID: 28257989
[TBL] [Abstract][Full Text] [Related]
18. Cyclodextrin-Based Delivery Systems for Arthritic Diseases: From Development to Experimental Therapeutics.
Monteiro Nascimento MH; Santos Akkari AC; Freitas Mariano KC; Kimus Braz AS; Lombello CB; de Araujo DR
Curr Pharm Des; 2015; 21(33):4907-16. PubMed ID: 26290205
[TBL] [Abstract][Full Text] [Related]
19. [New strategies for treatment of rheumatoid arthritis].
Kashiwazaki S
Nihon Rinsho; 1997 Sep; 55(9):2467-75. PubMed ID: 9301317
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis.
Natarajan V; Krithica N; Madhan B; Sehgal PK
J Pharm Sci; 2011 Jan; 100(1):195-205. PubMed ID: 20607810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
